Cargando…
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration
Human immunodeficiency virus type 1 (HIV-1) is known to provoke microglial immune responses which likely play a paramount role in the development of chronic neuroinflammatory conditions and neuronal damage related to HIV-1 associated neurocognitive disorders (HAND). In particular, HIV-1 Tat protein...
Autores principales: | Hermes, Douglas J., Yadav-Samudrala, Barkha J., Xu, Changqing, Paniccia, Jacqueline E., Meeker, Rick B., Armstrong, Michael L., Reisdorph, Nichole, Cravatt, Benjamin F., Mackie, Ken, Lichtman, Aron H., Ignatowska-Jankowska, Bogna M., Lysle, Donald T., Fitting, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984429/ https://www.ncbi.nlm.nih.gov/pubmed/33736974 http://dx.doi.org/10.1016/j.expneurol.2021.113699 |
Ejemplares similares
-
Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms
por: Xu, Changqing, et al.
Publicado: (2022) -
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat
por: League, Alexis F., et al.
Publicado: (2021) -
Inhibitory Control Deficits Associated with Upregulation of CB(1)R in the HIV-1 Tat Transgenic Mouse Model of Hand
por: Jacobs, Ian R., et al.
Publicado: (2019) -
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids
por: Hermes, Douglas J., et al.
Publicado: (2020) -
Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors
por: Xu, Changqing, et al.
Publicado: (2016)